CureDuchenne to Host Webinar with TRiNDS on a New Solution for the Duchenne Research Community

NEWPORT BEACH, Calif., January 16, 2017 –  CureDuchenne, a nonprofit dedicated to funding research and improving patient care for Duchenne muscular dystrophy, will host a webinar with TRiNDS, a new specialized contract research organization for neuromuscular diseases, on January 24 at 1 p.m. EST/10 a.m. PST. The webinar is an opportunity for the Duchenne community to learn about neuromuscular research and clinical trial development.

TRiNDS provides four main pillars of solutions in clinical operations, data management, biostatistics and study measurements.  It is unique with its focus on muscular dystrophies and study outcome developments. It is built on the expertise established with the academic clinical trial network Cooperative International Neuromuscular Research Group (CINRG). TRiNDS bridges the gaps for neuromuscular research by drawing in the key leaders in the field.

TRiNDS’ Chief Operating Officer, Lauren Morgenroth, and Director of Data Management, Adrienne Arrieta, will present during the webinar.  The session will be moderated Dr. Jak Knowles, Vice President Medical and Scientific Affairs, CureDuchenne.

To register for the webinar on January 24, click here.  The call in number is (844) 337-8088 and conference ID is 53815728.

About CureDuchenne

CureDuchenne was founded in 2003 with a focus on saving the lives of those with Duchenne muscular dystrophy, a disease that affects more than 300,000 boys worldwide. With support from CureDuchenne, nine research projects have advanced to human clinical trials. CureDuchenne also is the innovator bringing physical therapy and standard of care to local communities around the country through CureDuchenne Cares.  For more information, please visit and follow us on Facebook, Twitter, Instagram and YouTube.

About TRiNDS

TRiNDS, LLC started operating in May of 2016 and is a contract research organization. TRiNDS combines international disease expertise with regulatory agency compliant data and project management services as well as study design, biostatistical analyses, and study measurements such as strength and function outcomes, and biomarkers. TRiNDS, LLC team has over 15 years of experience coordinating neuromuscular clinical research studies. For more information, please visit



Related Posts

Share This Page

Make an Impact

You can advance the care, treatment and cure for Duchenne muscular dystrophy. Contributions in any amount can truly make a difference and can be credited to a fundraiser or event from the list below.